- BioPharm International-08-01-2002
- Volume 15
- Issue 8
Survival Guide to FDA Inspections: Part 1, To Prepare or Not to Prepare, There Is No Question
by Massoud Lavian and Paul W. Allen, Clarkston Consulting Would your company survive a surprise inspection? An FDA inspection can be a nightmare that costs your company money, time, and reputation. Proactive managers understand the logic behind FDA regulations and prepare accordingly. This three-part survival guide to inspections (whether from FDA, a client, an investor, or a European agency) will sharpen your vision of your company?s regulatory compliance picture.
Articles in this issue
about 23 years ago
Guest Editorial: Quality Agreements with Contract Laboratoriesabout 23 years ago
Inside Washington: User Fee Program Seeks to Spur Biotech Developmentabout 23 years ago
Analytical Advances: Mapping Proteins – the 2-D Electrophoresis Issueabout 23 years ago
Your Vested Interests: Gorillas In Our MidstNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.